206 related articles for article (PubMed ID: 30446458)
21. Lymphadenectomy for renal cell carcinoma and urothelial carcinoma of the upper urinary tract: analysis of evidence in the minimally invasive era.
Geller R; Hemal S; Manny T
Minerva Med; 2013 Jun; 104(3):261-72. PubMed ID: 23748280
[TBL] [Abstract][Full Text] [Related]
22. Impact of L4 lymph node dissection on long-term survival in left-side operable non-small-cell lung cancer: a propensity score matching study.
Yang MZ; Hou X; Li JB; Cai JS; Yang J; Li S; Long H; Fu JH; Zhang LJ; Lin P; Rong TH; Yang HX
Eur J Cardiothorac Surg; 2020 Jun; 57(6):1181-1188. PubMed ID: 32016340
[TBL] [Abstract][Full Text] [Related]
23. Radical Nephrectomy with or without Lymph Node Dissection for pT3 Renal Cell Carcinoma: A Propensity Score-based Analysis.
Li P; Peng C; Gu L; Xie Y; Nie W; Zhang Y; Xuan Y; Shen D; Du S; Tang L; Yao Y; Fan Y; Ma X; Zhang X
J Cancer; 2019; 10(10):2369-2375. PubMed ID: 31258740
[TBL] [Abstract][Full Text] [Related]
24. Partial nephrectomy is not associated with an overall survival advantage over radical nephrectomy in elderly patients with stage Ib-II renal masses: An analysis of the national cancer data base.
Ristau BT; Handorf EA; Cahn DB; Kutikov A; Uzzo RG; Smaldone MC
Cancer; 2018 Oct; 124(19):3839-3848. PubMed ID: 30207380
[TBL] [Abstract][Full Text] [Related]
25. Lymph node dissection should not be dismissed in case of localized renal cell carcinoma in the presence of larger diseases.
Dell'Oglio P; Larcher A; Muttin F; Di Trapani E; Trevisani F; Ripa F; Carenzi C; Briganti A; Salonia A; Montorsi F; Bertini R; Capitanio U
Urol Oncol; 2017 Nov; 35(11):662.e9-662.e15. PubMed ID: 28801027
[TBL] [Abstract][Full Text] [Related]
26. Radical Nephrectomy with or without Lymph Node Dissection for High Risk Nonmetastatic Renal Cell Carcinoma: A Multi-Institutional Analysis.
Gershman B; Thompson RH; Boorjian SA; Larcher A; Capitanio U; Montorsi F; Carenzi C; Bertini R; Briganti A; Lohse CM; Cheville JC; Leibovich BC
J Urol; 2018 May; 199(5):1143-1148. PubMed ID: 29225056
[TBL] [Abstract][Full Text] [Related]
27. The rationale and the role of lymph node dissection in renal cell carcinoma.
Capitanio U; Leibovich BC
World J Urol; 2017 Apr; 35(4):497-506. PubMed ID: 27364520
[TBL] [Abstract][Full Text] [Related]
28. Systematic review of adrenalectomy and lymph node dissection in locally advanced renal cell carcinoma.
Bekema HJ; MacLennan S; Imamura M; Lam TB; Stewart F; Scott N; MacLennan G; McClinton S; Griffiths TR; Skolarikos A; MacLennan SJ; Sylvester R; Ljungberg B; N'Dow J
Eur Urol; 2013 Nov; 64(5):799-810. PubMed ID: 23643550
[TBL] [Abstract][Full Text] [Related]
29. Factors affecting lymph node sampling patterns and the impact on survival of lymph node density in patients with Wilms tumor: a Surveillance, Epidemiology, and End Result (SEER) database review.
Walker JP; Johnson JS; Eguchi MM; Saltzman AF; Cockburn M; Cost NG
J Pediatr Urol; 2020 Feb; 16(1):81-88. PubMed ID: 31791906
[TBL] [Abstract][Full Text] [Related]
30. The role of lymph node dissection in the contemporary management of renal cell carcinoma: A critical appraisal of the evidence.
Brito J; Gershman B
Urol Oncol; 2017 Nov; 35(11):623-626. PubMed ID: 28712789
[TBL] [Abstract][Full Text] [Related]
31. Staging lymphadenectomy in renal cell carcinoma must be extended: a sensitivity curve analysis.
Capitanio U; Suardi N; Matloob R; Abdollah F; Castiglione F; Briganti A; Carenzi C; Roscigno M; Montorsi F; Bertini R
BJU Int; 2013 Mar; 111(3):412-8. PubMed ID: 22703190
[TBL] [Abstract][Full Text] [Related]
32. Laparoscopic radical nephrectomy with hilar lymph node dissection in patients with advanced renal cell carcinoma.
Simmons MN; Kaouk J; Gill IS; Fergany A
Urology; 2007 Jul; 70(1):43-6. PubMed ID: 17656205
[TBL] [Abstract][Full Text] [Related]
33. Analysis of lymph node dissection in patients with ≥7-cm renal tumors.
Feuerstein MA; Kent M; Bazzi WM; Bernstein M; Russo P
World J Urol; 2014 Dec; 32(6):1531-6. PubMed ID: 24402173
[TBL] [Abstract][Full Text] [Related]
34. Extended vs standard lymph node dissection in robot-assisted radical prostatectomy for intermediate- or high-risk prostate cancer: a propensity-score-matching analysis.
Kim KH; Lim SK; Kim HY; Shin TY; Lee JY; Choi YD; Chung BH; Hong SJ; Rha KH
BJU Int; 2013 Jul; 112(2):216-23. PubMed ID: 23356436
[TBL] [Abstract][Full Text] [Related]
35. Lymph Node Density as an Independent Prognostic Factor in Node-Positive Renal-Cell Carcinoma: Results From the Surveillance, Epidemiology, and End Results Program.
Liao X; Qiu S; Zheng X; Ai J; Jin X; Gong L; Bao Y; Jin K; Li H; Yang L; Wei Q
Clin Genitourin Cancer; 2019 Oct; 17(5):e968-e980. PubMed ID: 31229458
[TBL] [Abstract][Full Text] [Related]
36. Effect of Lymph Node Dissection on the Prognosis of Thymic Carcinomas and Thymic Neuroendocrine Tumors.
Wang ZM; Li F; Liu XY; Nachira D; Badakhshi H; Rückert JC; Ismail M
Semin Thorac Cardiovasc Surg; 2021 Summer; 33(2):568-578. PubMed ID: 33181313
[TBL] [Abstract][Full Text] [Related]
37. Survival implications of staging lymphadenectomy for non-endometrioid endometrial cancers.
Venigalla S; Chowdhry AK; Shalowitz DI
Gynecol Oncol; 2018 Jun; 149(3):531-538. PubMed ID: 29559170
[TBL] [Abstract][Full Text] [Related]
38. Lack of Effectiveness of Postchemotherapy Lymphadenectomy in Bladder Cancer Patients with Clinical Evidence of Metastatic Pelvic or Retroperitoneal Lymph Nodes Only: A Propensity Score-based Analysis.
Necchi A; Mariani L; Lo Vullo S; Yu EY; Woods ME; Wong YN; Harshman LC; Alva A; Sternberg CN; Bamias A; Grivas P; Koshkin VS; Roghmann F; Dobruch J; Eigl BJ; Nappi L; Milowsky MI; Niegisch G; Pal SK; De Giorgi U; Recine F; Vaishampayan U; Berthold DD; Bowles DW; Baniel J; Theodore C; Ladoire S; Srinivas S; Agarwal N; Crabb S; Sridhar S; Golshayan AR; Ohlmann C; Xylinas E; Powles T; Rosenberg JE; Bellmunt J; van Rhijn B; Galsky MD; Hendricksen K;
Eur Urol Focus; 2019 Mar; 5(2):242-249. PubMed ID: 28753897
[TBL] [Abstract][Full Text] [Related]
39. Role of surgical approach on lymph node dissection yield and survival in patients with upper tract urothelial carcinoma.
Lenis AT; Donin NM; Faiena I; Salmasi A; Johnson DC; Drakaki A; Gollapudi K; Blumberg J; Belldegrun A; Pantuck A; Chamie K
Urol Oncol; 2018 Jan; 36(1):9.e1-9.e9. PubMed ID: 29066013
[TBL] [Abstract][Full Text] [Related]
40. Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.
Simone G; Tuderti G; Anceschi U; Papalia R; Ferriero M; Misuraca L; Minisola F; Mastroianni R; Costantini M; Guaglianone S; Sentinelli S; Gallucci M
World J Urol; 2017 May; 35(5):789-794. PubMed ID: 27578234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
